Giovanni Di Minno Selected Research

Giovanni Di Minno Research Topics

Disease

31	Hemorrhage 12/2021 - 01/2006
28	Hemophilia A (Haemophilia) 06/2022 - 01/2007
12	Thrombosis (Thrombus) 01/2020 - 09/2002
9	Thrombasthenia (Glanzmann Thrombasthenia) 07/2019 - 12/2004
9	Venous Thromboembolism 01/2019 - 11/2006
8	Stroke (Strokes) 04/2017 - 04/2011
7	Neoplasms (Cancer) 01/2019 - 04/2011
7	Atrial Fibrillation 06/2017 - 01/2012
5	Vascular Diseases (Vascular Disease) 06/2015 - 09/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 07/2019 - 04/2003
4	Thrombophilia 08/2014 - 08/2002
3	Psoriatic Arthritis 05/2012 - 03/2011
2	Splenomegaly 12/2021 - 11/2017
2	Joint Diseases (Joint Disease) 01/2021 - 07/2011
2	Peripheral Arterial Disease 01/2021 - 01/2010
2	Pain (Aches) 01/2021 - 07/2011
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2019 - 05/2010
2	Renal Insufficiency (Renal Failure) 01/2019 - 04/2017
2	Hematologic Neoplasms (Hematological Malignancy) 11/2017 - 04/2011
2	Chronic Renal Insufficiency 06/2017 - 05/2010
2	Hyperhomocysteinemia 09/2013 - 10/2011
2	Factor VII Deficiency (Hypoproconvertinemia) 04/2013 - 02/2013
2	Acute Coronary Syndrome 11/2012 - 08/2009
2	Atherosclerosis 07/2012 - 03/2011
2	Inflammation (Inflammations) 07/2012 - 03/2011
2	Diabetic Angiopathies (Diabetic Angiopathy) 03/2012 - 01/2004
2	Embolic Stroke 01/2012 - 11/2011
2	Thrombocytopenia (Thrombopenia) 04/2011 - 03/2007
2	Ischemic Stroke 04/2011 - 01/2002
2	Coronary Disease (Coronary Heart Disease) 10/2010 - 09/2002
2	Myocardial Infarction 10/2010 - 09/2002
2	Sudden Death 10/2010 - 09/2002
2	Hypercholesterolemia 07/2005 - 10/2004
1	COVID-19 02/2022
1	Hematoma 12/2021
1	Disease Susceptibility (Diathesis) 12/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Pneumonia (Pneumonitis) 01/2019

Drug/Important Bio-Agent (IBA)

12	Factor VIII (Coagulation Factor VIII)IBA 06/2022 - 01/2007
11	recombinant FVIIa (rFVIIa)FDA Link 07/2019 - 12/2004
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 08/2002
9	AnticoagulantsIBA 01/2019 - 11/2011
8	Factor VIIa (Activated Factor VII)IBA 01/2020 - 01/2006
8	AntibodiesIBA 07/2019 - 01/2006
6	Warfarin (Coumadin)FDA LinkGeneric 12/2015 - 02/2012
5	Blood Coagulation Factors (Coagulation Factor)IBA 12/2021 - 08/2011
5	Pharmaceutical PreparationsIBA 11/2021 - 01/2010
5	Prothrombin (Factor II)IBA 01/2020 - 01/2002
4	emicizumabIBA 11/2021 - 01/2019
4	AutoantibodiesIBA 01/2020 - 01/2010
4	Thrombin FDA Link 01/2020 - 11/2012
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 08/2009
4	IntegrinsIBA 08/2018 - 12/2009
4	Dabigatran FDA Link 06/2017 - 11/2012
4	Vitamin K FDA Link 01/2017 - 11/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012 - 03/2011
3	Clopidogrel (Plavix)FDA Link 01/2021 - 08/2009
3	Antiphospholipid AntibodiesIBA 07/2019 - 05/2010
3	Rituximab (Mabthera)FDA Link 11/2017 - 01/2015
3	AntithrombinsIBA 06/2017 - 01/2014
3	Platelet Membrane Glycoprotein IIbIBA 04/2016 - 01/2006
3	Folic Acid (Vitamin M)FDA LinkGeneric 06/2015 - 10/2005
3	Protein SIBA 05/2015 - 04/2003
3	factor V LeidenIBA 01/2014 - 01/2002
2	human F8 protein FDA Link 06/2022 - 01/2020
2	CollagenIBA 12/2021 - 03/2007
2	Factor V (Coagulation Factor V)IBA 12/2021 - 01/2002
2	Factor VII (Proconvertin)IBA 12/2021 - 04/2013
2	TicagrelorIBA 01/2021 - 06/2013
2	fitusiranIBA 01/2020 - 01/2019
2	concizumabIBA 01/2020 - 01/2019
2	Fibrinogen ReceptorsIBA 07/2017 - 04/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 04/2016 - 06/2015
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 04/2016 - 08/2015
2	Monoclonal AntibodiesIBA 01/2016 - 01/2015
2	apixabanIBA 07/2015 - 11/2012
2	RivaroxabanIBA 07/2015 - 11/2012
2	Protein CIBA 05/2015 - 01/2014
2	HomocysteineIBA 05/2010 - 01/2002
2	Heparin (Liquaemin)FDA LinkGeneric 08/2009 - 08/2002
2	Hemostatics (Antihemorrhagics)IBA 03/2007 - 01/2006
2	CholesterolIBA 07/2005 - 10/2004
1	Arachidonic Acid (Vitamin F)IBA 12/2021
1	RistocetinIBA 12/2021
1	Factor XIII (Coagulation Factor XIII)IBA 12/2021
1	Factor X (Stuart Factor)IBA 12/2021
1	Thromboplastin (Tissue Factor)IBA 12/2021
1	VaccinesIBA 07/2019
1	Zoledronic Acid (Zometa)FDA Link 01/2019

Therapy/Procedure

13	Therapeutics 01/2021 - 11/2006
5	Platelet Transfusion (Blood Platelet Transfusions) 07/2019 - 01/2006
3	Secondary Prevention 04/2017 - 09/2002
2	Surgical Amputation (Amputations) 01/2021 - 11/2014
2	Precision Medicine 01/2020 - 01/2017
2	Operative Surgical Procedures 04/2016 - 08/2015
1	Critical Care (Surgical Intensive Care) 02/2022
1	Injections 07/2021
1	Pain Management 01/2021
1	Intravenous Infusions 01/2020
1	Subcutaneous Injections 01/2020